Decibel Therapeutics, Inc. Retained Earnings
Decibel Therapeutics, Inc. had Retained Earnings of -$308.97 million as of 2023-06-30, per its 10-Q filed 2023-08-11.
Discontinued › Balance Sheet › Equity › Equity, Attributable to Parent
us-gaap:RetainedEarningsAccumulatedDeficit · last filed 2023-08-11
- 2023-06-30: Retained Earnings (Accumulated Deficit) -$308.97M.
- 2023-03-31: Retained Earnings (Accumulated Deficit) -$290.82M.
- 2022-12-31: Retained Earnings (Accumulated Deficit) -$277.52M.
- 2022-09-30: Retained Earnings (Accumulated Deficit) -$261.58M.
| Period end | Retained Earnings (Accumulated Deficit) |
|---|---|
| 2023-06-30 | -$308.97M 10-Q · filed 2023-08-11 |
| 2023-03-31 | -$290.82M 10-Q · filed 2023-05-15 |
| 2022-12-31 | -$277.52M 10-Q · filed 2023-08-11 |
| 2022-09-30 | -$261.58M 10-Q · filed 2022-11-09 |
| 2022-06-30 | -$245.57M 10-Q · filed 2022-08-10 |
| 2022-03-31 | -$228.53M 10-Q · filed 2022-05-12 |
| 2021-12-31 | -$214.51M 10-K · filed 2023-03-14 |
| 2021-09-30 | -$201.61M 10-Q · filed 2021-11-10 |
| 2021-06-30 | -$185.21M 10-Q · filed 2021-08-10 |
| 2021-03-31 | -$173.56M 10-Q · filed 2021-05-13 |
| 2020-12-31 | -$162.69M 10-K · filed 2022-03-18 |